nodes	percent_of_prediction	percent_of_DWPC	metapath
Dantrolene—CYP3A4—Estropipate—osteoporosis	0.102	0.181	CbGbCtD
Dantrolene—CYP3A4—Calcitriol—osteoporosis	0.102	0.181	CbGbCtD
Dantrolene—CYP3A4—Ergocalciferol—osteoporosis	0.0815	0.145	CbGbCtD
Dantrolene—CYP3A4—Raloxifene—osteoporosis	0.068	0.121	CbGbCtD
Dantrolene—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0657	0.117	CbGbCtD
Dantrolene—CYP3A4—Cholecalciferol—osteoporosis	0.0525	0.0934	CbGbCtD
Dantrolene—CYP3A4—Conjugated Estrogens—osteoporosis	0.0482	0.0858	CbGbCtD
Dantrolene—CYP3A4—Estradiol—osteoporosis	0.0423	0.0753	CbGbCtD
Dantrolene—Gastrointestinal pain—Raloxifene—osteoporosis	0.000732	0.00167	CcSEcCtD
Dantrolene—Diarrhoea—Etidronic acid—osteoporosis	0.000731	0.00167	CcSEcCtD
Dantrolene—Haematuria—Estradiol—osteoporosis	0.000731	0.00167	CcSEcCtD
Dantrolene—Body temperature increased—Estropipate—osteoporosis	0.000731	0.00167	CcSEcCtD
Dantrolene—Abdominal pain—Estropipate—osteoporosis	0.000731	0.00167	CcSEcCtD
Dantrolene—Feeling abnormal—Ibandronate—osteoporosis	0.000731	0.00167	CcSEcCtD
Dantrolene—Nervousness—Conjugated Estrogens—osteoporosis	0.000727	0.00166	CcSEcCtD
Dantrolene—Gastrointestinal pain—Ibandronate—osteoporosis	0.000725	0.00166	CcSEcCtD
Dantrolene—Myalgia—Pamidronate—osteoporosis	0.000725	0.00165	CcSEcCtD
Dantrolene—Back pain—Conjugated Estrogens—osteoporosis	0.000724	0.00165	CcSEcCtD
Dantrolene—Urticaria—Alendronate—osteoporosis	0.000724	0.00165	CcSEcCtD
Dantrolene—Ill-defined disorder—Zoledronate—osteoporosis	0.000721	0.00165	CcSEcCtD
Dantrolene—Abdominal pain—Alendronate—osteoporosis	0.00072	0.00164	CcSEcCtD
Dantrolene—Body temperature increased—Alendronate—osteoporosis	0.00072	0.00164	CcSEcCtD
Dantrolene—Anaemia—Zoledronate—osteoporosis	0.000719	0.00164	CcSEcCtD
Dantrolene—Discomfort—Pamidronate—osteoporosis	0.000716	0.00163	CcSEcCtD
Dantrolene—Gastrointestinal pain—Calcitriol—osteoporosis	0.00071	0.00162	CcSEcCtD
Dantrolene—Abdominal pain—Raloxifene—osteoporosis	0.000708	0.00162	CcSEcCtD
Dantrolene—Body temperature increased—Raloxifene—osteoporosis	0.000708	0.00162	CcSEcCtD
Dantrolene—Vision blurred—Conjugated Estrogens—osteoporosis	0.000706	0.00161	CcSEcCtD
Dantrolene—Urticaria—Ibandronate—osteoporosis	0.000704	0.00161	CcSEcCtD
Dantrolene—Malaise—Zoledronate—osteoporosis	0.000701	0.0016	CcSEcCtD
Dantrolene—Abdominal pain—Ibandronate—osteoporosis	0.000701	0.0016	CcSEcCtD
Dantrolene—Body temperature increased—Ibandronate—osteoporosis	0.000701	0.0016	CcSEcCtD
Dantrolene—Confusional state—Pamidronate—osteoporosis	0.0007	0.0016	CcSEcCtD
Dantrolene—Leukopenia—Zoledronate—osteoporosis	0.000696	0.00159	CcSEcCtD
Dantrolene—Anaphylactic shock—Pamidronate—osteoporosis	0.000695	0.00159	CcSEcCtD
Dantrolene—Haemoglobin—Estradiol—osteoporosis	0.000692	0.00158	CcSEcCtD
Dantrolene—Urticaria—Calcitriol—osteoporosis	0.00069	0.00157	CcSEcCtD
Dantrolene—Hepatitis—Estradiol—osteoporosis	0.000688	0.00157	CcSEcCtD
Dantrolene—Haemorrhage—Estradiol—osteoporosis	0.000688	0.00157	CcSEcCtD
Dantrolene—Abdominal pain—Calcitriol—osteoporosis	0.000686	0.00157	CcSEcCtD
Dantrolene—Body temperature increased—Calcitriol—osteoporosis	0.000686	0.00157	CcSEcCtD
Dantrolene—Hypersensitivity—Estropipate—osteoporosis	0.000681	0.00156	CcSEcCtD
Dantrolene—Thrombocytopenia—Pamidronate—osteoporosis	0.00068	0.00155	CcSEcCtD
Dantrolene—Vomiting—Etidronic acid—osteoporosis	0.00068	0.00155	CcSEcCtD
Dantrolene—Tachycardia—Pamidronate—osteoporosis	0.000678	0.00155	CcSEcCtD
Dantrolene—Rash—Etidronic acid—osteoporosis	0.000674	0.00154	CcSEcCtD
Dantrolene—Convulsion—Zoledronate—osteoporosis	0.000674	0.00154	CcSEcCtD
Dantrolene—Dermatitis—Etidronic acid—osteoporosis	0.000673	0.00154	CcSEcCtD
Dantrolene—Hyperhidrosis—Pamidronate—osteoporosis	0.000672	0.00153	CcSEcCtD
Dantrolene—Hypertension—Zoledronate—osteoporosis	0.000671	0.00153	CcSEcCtD
Dantrolene—Hypersensitivity—Alendronate—osteoporosis	0.000671	0.00153	CcSEcCtD
Dantrolene—Headache—Etidronic acid—osteoporosis	0.00067	0.00153	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000666	0.00152	CcSEcCtD
Dantrolene—Asthenia—Estropipate—osteoporosis	0.000663	0.00151	CcSEcCtD
Dantrolene—Visual impairment—Estradiol—osteoporosis	0.000663	0.00151	CcSEcCtD
Dantrolene—Anorexia—Pamidronate—osteoporosis	0.000662	0.00151	CcSEcCtD
Dantrolene—Myalgia—Zoledronate—osteoporosis	0.000662	0.00151	CcSEcCtD
Dantrolene—Insomnia—Risedronate—osteoporosis	0.000661	0.00151	CcSEcCtD
Dantrolene—Pruritus—Estropipate—osteoporosis	0.000654	0.00149	CcSEcCtD
Dantrolene—Discomfort—Zoledronate—osteoporosis	0.000654	0.00149	CcSEcCtD
Dantrolene—Asthenia—Alendronate—osteoporosis	0.000653	0.00149	CcSEcCtD
Dantrolene—Hypersensitivity—Ibandronate—osteoporosis	0.000653	0.00149	CcSEcCtD
Dantrolene—Convulsion—Conjugated Estrogens—osteoporosis	0.000649	0.00148	CcSEcCtD
Dantrolene—Dry mouth—Zoledronate—osteoporosis	0.000647	0.00148	CcSEcCtD
Dantrolene—Fatigue—Ethinyl Estradiol—osteoporosis	0.000646	0.00148	CcSEcCtD
Dantrolene—Pruritus—Alendronate—osteoporosis	0.000644	0.00147	CcSEcCtD
Dantrolene—Dyspepsia—Risedronate—osteoporosis	0.000643	0.00147	CcSEcCtD
Dantrolene—Constipation—Ethinyl Estradiol—osteoporosis	0.000641	0.00146	CcSEcCtD
Dantrolene—Confusional state—Zoledronate—osteoporosis	0.00064	0.00146	CcSEcCtD
Dantrolene—Hypersensitivity—Calcitriol—osteoporosis	0.00064	0.00146	CcSEcCtD
Dantrolene—Flushing—Estradiol—osteoporosis	0.000639	0.00146	CcSEcCtD
Dantrolene—Myalgia—Conjugated Estrogens—osteoporosis	0.000637	0.00146	CcSEcCtD
Dantrolene—Asthenia—Ibandronate—osteoporosis	0.000636	0.00145	CcSEcCtD
Dantrolene—Nausea—Etidronic acid—osteoporosis	0.000635	0.00145	CcSEcCtD
Dantrolene—Anaphylactic shock—Zoledronate—osteoporosis	0.000635	0.00145	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000633	0.00145	CcSEcCtD
Dantrolene—Diarrhoea—Estropipate—osteoporosis	0.000633	0.00144	CcSEcCtD
Dantrolene—Fatigue—Risedronate—osteoporosis	0.00063	0.00144	CcSEcCtD
Dantrolene—Insomnia—Pamidronate—osteoporosis	0.000628	0.00143	CcSEcCtD
Dantrolene—Pruritus—Ibandronate—osteoporosis	0.000627	0.00143	CcSEcCtD
Dantrolene—Pain—Risedronate—osteoporosis	0.000625	0.00143	CcSEcCtD
Dantrolene—Constipation—Risedronate—osteoporosis	0.000625	0.00143	CcSEcCtD
Dantrolene—Diarrhoea—Alendronate—osteoporosis	0.000623	0.00142	CcSEcCtD
Dantrolene—Asthenia—Calcitriol—osteoporosis	0.000623	0.00142	CcSEcCtD
Dantrolene—Thrombocytopenia—Zoledronate—osteoporosis	0.000621	0.00142	CcSEcCtD
Dantrolene—Tachycardia—Zoledronate—osteoporosis	0.000619	0.00141	CcSEcCtD
Dantrolene—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000618	0.00141	CcSEcCtD
Dantrolene—Chills—Estradiol—osteoporosis	0.000618	0.00141	CcSEcCtD
Dantrolene—Somnolence—Pamidronate—osteoporosis	0.000618	0.00141	CcSEcCtD
Dantrolene—Pruritus—Calcitriol—osteoporosis	0.000614	0.0014	CcSEcCtD
Dantrolene—Hyperhidrosis—Zoledronate—osteoporosis	0.000613	0.0014	CcSEcCtD
Dantrolene—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000613	0.0014	CcSEcCtD
Dantrolene—Diarrhoea—Raloxifene—osteoporosis	0.000613	0.0014	CcSEcCtD
Dantrolene—Dyspepsia—Pamidronate—osteoporosis	0.000612	0.0014	CcSEcCtD
Dantrolene—Dizziness—Estropipate—osteoporosis	0.000611	0.0014	CcSEcCtD
Dantrolene—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000611	0.00139	CcSEcCtD
Dantrolene—Diarrhoea—Ibandronate—osteoporosis	0.000607	0.00139	CcSEcCtD
Dantrolene—Anorexia—Zoledronate—osteoporosis	0.000605	0.00138	CcSEcCtD
Dantrolene—Decreased appetite—Pamidronate—osteoporosis	0.000604	0.00138	CcSEcCtD
Dantrolene—Dizziness—Alendronate—osteoporosis	0.000602	0.00138	CcSEcCtD
Dantrolene—Erythema—Estradiol—osteoporosis	0.000599	0.00137	CcSEcCtD
Dantrolene—Fatigue—Pamidronate—osteoporosis	0.000599	0.00137	CcSEcCtD
Dantrolene—Gastrointestinal pain—Risedronate—osteoporosis	0.000598	0.00136	CcSEcCtD
Dantrolene—Tachycardia—Conjugated Estrogens—osteoporosis	0.000596	0.00136	CcSEcCtD
Dantrolene—Urticaria—Ethinyl Estradiol—osteoporosis	0.000595	0.00136	CcSEcCtD
Dantrolene—Pain—Pamidronate—osteoporosis	0.000594	0.00136	CcSEcCtD
Dantrolene—Constipation—Pamidronate—osteoporosis	0.000594	0.00136	CcSEcCtD
Dantrolene—Diarrhoea—Calcitriol—osteoporosis	0.000594	0.00136	CcSEcCtD
Dantrolene—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000593	0.00135	CcSEcCtD
Dantrolene—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000593	0.00135	CcSEcCtD
Dantrolene—Dizziness—Raloxifene—osteoporosis	0.000592	0.00135	CcSEcCtD
Dantrolene—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000591	0.00135	CcSEcCtD
Dantrolene—Tension—Estradiol—osteoporosis	0.000588	0.00134	CcSEcCtD
Dantrolene—Vomiting—Estropipate—osteoporosis	0.000588	0.00134	CcSEcCtD
Dantrolene—Dysgeusia—Estradiol—osteoporosis	0.000587	0.00134	CcSEcCtD
Dantrolene—Dizziness—Ibandronate—osteoporosis	0.000586	0.00134	CcSEcCtD
Dantrolene—Rash—Estropipate—osteoporosis	0.000583	0.00133	CcSEcCtD
Dantrolene—Dermatitis—Estropipate—osteoporosis	0.000583	0.00133	CcSEcCtD
Dantrolene—Anorexia—Conjugated Estrogens—osteoporosis	0.000582	0.00133	CcSEcCtD
Dantrolene—Nervousness—Estradiol—osteoporosis	0.000582	0.00133	CcSEcCtD
Dantrolene—Urticaria—Risedronate—osteoporosis	0.000581	0.00133	CcSEcCtD
Dantrolene—Back pain—Estradiol—osteoporosis	0.00058	0.00132	CcSEcCtD
Dantrolene—Headache—Estropipate—osteoporosis	0.000579	0.00132	CcSEcCtD
Dantrolene—Vomiting—Alendronate—osteoporosis	0.000579	0.00132	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000578	0.00132	CcSEcCtD
Dantrolene—Abdominal pain—Risedronate—osteoporosis	0.000578	0.00132	CcSEcCtD
Dantrolene—Body temperature increased—Risedronate—osteoporosis	0.000578	0.00132	CcSEcCtD
Dantrolene—Rash—Alendronate—osteoporosis	0.000574	0.00131	CcSEcCtD
Dantrolene—Insomnia—Zoledronate—osteoporosis	0.000574	0.00131	CcSEcCtD
Dantrolene—Dermatitis—Alendronate—osteoporosis	0.000574	0.00131	CcSEcCtD
Dantrolene—Feeling abnormal—Pamidronate—osteoporosis	0.000572	0.00131	CcSEcCtD
Dantrolene—Headache—Alendronate—osteoporosis	0.000571	0.0013	CcSEcCtD
Dantrolene—Vomiting—Raloxifene—osteoporosis	0.00057	0.0013	CcSEcCtD
Dantrolene—Gastrointestinal pain—Pamidronate—osteoporosis	0.000568	0.0013	CcSEcCtD
Dantrolene—Rash—Raloxifene—osteoporosis	0.000565	0.00129	CcSEcCtD
Dantrolene—Dermatitis—Raloxifene—osteoporosis	0.000564	0.00129	CcSEcCtD
Dantrolene—Somnolence—Zoledronate—osteoporosis	0.000564	0.00129	CcSEcCtD
Dantrolene—Vomiting—Ibandronate—osteoporosis	0.000564	0.00129	CcSEcCtD
Dantrolene—Headache—Raloxifene—osteoporosis	0.000561	0.00128	CcSEcCtD
Dantrolene—Rash—Ibandronate—osteoporosis	0.000559	0.00128	CcSEcCtD
Dantrolene—Dermatitis—Ibandronate—osteoporosis	0.000559	0.00128	CcSEcCtD
Dantrolene—Dyspepsia—Zoledronate—osteoporosis	0.000559	0.00128	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000557	0.00127	CcSEcCtD
Dantrolene—Ill-defined disorder—Estradiol—osteoporosis	0.000556	0.00127	CcSEcCtD
Dantrolene—Headache—Ibandronate—osteoporosis	0.000556	0.00127	CcSEcCtD
Dantrolene—Insomnia—Conjugated Estrogens—osteoporosis	0.000553	0.00126	CcSEcCtD
Dantrolene—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000552	0.00126	CcSEcCtD
Dantrolene—Vomiting—Calcitriol—osteoporosis	0.000552	0.00126	CcSEcCtD
Dantrolene—Decreased appetite—Zoledronate—osteoporosis	0.000552	0.00126	CcSEcCtD
Dantrolene—Nausea—Estropipate—osteoporosis	0.000549	0.00125	CcSEcCtD
Dantrolene—Abdominal pain—Pamidronate—osteoporosis	0.000549	0.00125	CcSEcCtD
Dantrolene—Body temperature increased—Pamidronate—osteoporosis	0.000549	0.00125	CcSEcCtD
Dantrolene—Rash—Calcitriol—osteoporosis	0.000547	0.00125	CcSEcCtD
Dantrolene—Fatigue—Zoledronate—osteoporosis	0.000547	0.00125	CcSEcCtD
Dantrolene—Dermatitis—Calcitriol—osteoporosis	0.000547	0.00125	CcSEcCtD
Dantrolene—Headache—Calcitriol—osteoporosis	0.000544	0.00124	CcSEcCtD
Dantrolene—Somnolence—Conjugated Estrogens—osteoporosis	0.000543	0.00124	CcSEcCtD
Dantrolene—Constipation—Zoledronate—osteoporosis	0.000543	0.00124	CcSEcCtD
Dantrolene—Pain—Zoledronate—osteoporosis	0.000543	0.00124	CcSEcCtD
Dantrolene—Nausea—Alendronate—osteoporosis	0.000541	0.00124	CcSEcCtD
Dantrolene—Malaise—Estradiol—osteoporosis	0.00054	0.00123	CcSEcCtD
Dantrolene—Hypersensitivity—Risedronate—osteoporosis	0.000538	0.00123	CcSEcCtD
Dantrolene—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000538	0.00123	CcSEcCtD
Dantrolene—Asthenia—Ethinyl Estradiol—osteoporosis	0.000538	0.00123	CcSEcCtD
Dantrolene—Nausea—Raloxifene—osteoporosis	0.000532	0.00121	CcSEcCtD
Dantrolene—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000531	0.00121	CcSEcCtD
Dantrolene—Pruritus—Ethinyl Estradiol—osteoporosis	0.00053	0.00121	CcSEcCtD
Dantrolene—Fatigue—Conjugated Estrogens—osteoporosis	0.000527	0.0012	CcSEcCtD
Dantrolene—Nausea—Ibandronate—osteoporosis	0.000527	0.0012	CcSEcCtD
Dantrolene—Asthenia—Risedronate—osteoporosis	0.000524	0.0012	CcSEcCtD
Dantrolene—Feeling abnormal—Zoledronate—osteoporosis	0.000523	0.00119	CcSEcCtD
Dantrolene—Pain—Conjugated Estrogens—osteoporosis	0.000523	0.00119	CcSEcCtD
Dantrolene—Constipation—Conjugated Estrogens—osteoporosis	0.000523	0.00119	CcSEcCtD
Dantrolene—Gastrointestinal pain—Zoledronate—osteoporosis	0.000519	0.00118	CcSEcCtD
Dantrolene—Hypertension—Estradiol—osteoporosis	0.000517	0.00118	CcSEcCtD
Dantrolene—Pruritus—Risedronate—osteoporosis	0.000517	0.00118	CcSEcCtD
Dantrolene—Nausea—Calcitriol—osteoporosis	0.000516	0.00118	CcSEcCtD
Dantrolene—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000513	0.00117	CcSEcCtD
Dantrolene—Hypersensitivity—Pamidronate—osteoporosis	0.000512	0.00117	CcSEcCtD
Dantrolene—Myalgia—Estradiol—osteoporosis	0.00051	0.00116	CcSEcCtD
Dantrolene—Urticaria—Zoledronate—osteoporosis	0.000504	0.00115	CcSEcCtD
Dantrolene—Discomfort—Estradiol—osteoporosis	0.000504	0.00115	CcSEcCtD
Dantrolene—Body temperature increased—Zoledronate—osteoporosis	0.000502	0.00115	CcSEcCtD
Dantrolene—Abdominal pain—Zoledronate—osteoporosis	0.000502	0.00115	CcSEcCtD
Dantrolene—Diarrhoea—Risedronate—osteoporosis	0.0005	0.00114	CcSEcCtD
Dantrolene—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.0005	0.00114	CcSEcCtD
Dantrolene—Dry mouth—Estradiol—osteoporosis	0.000499	0.00114	CcSEcCtD
Dantrolene—Asthenia—Pamidronate—osteoporosis	0.000498	0.00114	CcSEcCtD
Dantrolene—Dizziness—Ethinyl Estradiol—osteoporosis	0.000496	0.00113	CcSEcCtD
Dantrolene—Confusional state—Estradiol—osteoporosis	0.000493	0.00113	CcSEcCtD
Dantrolene—Pruritus—Pamidronate—osteoporosis	0.000492	0.00112	CcSEcCtD
Dantrolene—Anaphylactic shock—Estradiol—osteoporosis	0.000489	0.00112	CcSEcCtD
Dantrolene—Urticaria—Conjugated Estrogens—osteoporosis	0.000485	0.00111	CcSEcCtD
Dantrolene—Dizziness—Risedronate—osteoporosis	0.000483	0.0011	CcSEcCtD
Dantrolene—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000483	0.0011	CcSEcCtD
Dantrolene—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000483	0.0011	CcSEcCtD
Dantrolene—Tachycardia—Estradiol—osteoporosis	0.000477	0.00109	CcSEcCtD
Dantrolene—Vomiting—Ethinyl Estradiol—osteoporosis	0.000477	0.00109	CcSEcCtD
Dantrolene—Diarrhoea—Pamidronate—osteoporosis	0.000475	0.00109	CcSEcCtD
Dantrolene—Hyperhidrosis—Estradiol—osteoporosis	0.000473	0.00108	CcSEcCtD
Dantrolene—Rash—Ethinyl Estradiol—osteoporosis	0.000473	0.00108	CcSEcCtD
Dantrolene—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000472	0.00108	CcSEcCtD
Dantrolene—Headache—Ethinyl Estradiol—osteoporosis	0.00047	0.00107	CcSEcCtD
Dantrolene—Hypersensitivity—Zoledronate—osteoporosis	0.000468	0.00107	CcSEcCtD
Dantrolene—Vomiting—Risedronate—osteoporosis	0.000465	0.00106	CcSEcCtD
Dantrolene—Rash—Risedronate—osteoporosis	0.000461	0.00105	CcSEcCtD
Dantrolene—Dermatitis—Risedronate—osteoporosis	0.00046	0.00105	CcSEcCtD
Dantrolene—Dizziness—Pamidronate—osteoporosis	0.000459	0.00105	CcSEcCtD
Dantrolene—Headache—Risedronate—osteoporosis	0.000458	0.00105	CcSEcCtD
Dantrolene—Asthenia—Zoledronate—osteoporosis	0.000455	0.00104	CcSEcCtD
Dantrolene—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00045	0.00103	CcSEcCtD
Dantrolene—Pruritus—Zoledronate—osteoporosis	0.000449	0.00102	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000446	0.00102	CcSEcCtD
Dantrolene—Nausea—Ethinyl Estradiol—osteoporosis	0.000445	0.00102	CcSEcCtD
Dantrolene—Insomnia—Estradiol—osteoporosis	0.000442	0.00101	CcSEcCtD
Dantrolene—Vomiting—Pamidronate—osteoporosis	0.000442	0.00101	CcSEcCtD
Dantrolene—Asthenia—Conjugated Estrogens—osteoporosis	0.000438	0.001	CcSEcCtD
Dantrolene—Rash—Pamidronate—osteoporosis	0.000438	0.001	CcSEcCtD
Dantrolene—Dermatitis—Pamidronate—osteoporosis	0.000438	0.000999	CcSEcCtD
Dantrolene—Headache—Pamidronate—osteoporosis	0.000435	0.000994	CcSEcCtD
Dantrolene—Somnolence—Estradiol—osteoporosis	0.000435	0.000993	CcSEcCtD
Dantrolene—Diarrhoea—Zoledronate—osteoporosis	0.000434	0.000991	CcSEcCtD
Dantrolene—Nausea—Risedronate—osteoporosis	0.000434	0.000991	CcSEcCtD
Dantrolene—Pruritus—Conjugated Estrogens—osteoporosis	0.000432	0.000987	CcSEcCtD
Dantrolene—Dyspepsia—Estradiol—osteoporosis	0.00043	0.000983	CcSEcCtD
Dantrolene—Decreased appetite—Estradiol—osteoporosis	0.000425	0.000971	CcSEcCtD
Dantrolene—Fatigue—Estradiol—osteoporosis	0.000422	0.000963	CcSEcCtD
Dantrolene—Dizziness—Zoledronate—osteoporosis	0.00042	0.000958	CcSEcCtD
Dantrolene—Pain—Estradiol—osteoporosis	0.000418	0.000955	CcSEcCtD
Dantrolene—Constipation—Estradiol—osteoporosis	0.000418	0.000955	CcSEcCtD
Dantrolene—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000418	0.000954	CcSEcCtD
Dantrolene—Nausea—Pamidronate—osteoporosis	0.000413	0.000942	CcSEcCtD
Dantrolene—Dizziness—Conjugated Estrogens—osteoporosis	0.000404	0.000922	CcSEcCtD
Dantrolene—Vomiting—Zoledronate—osteoporosis	0.000403	0.000921	CcSEcCtD
Dantrolene—Feeling abnormal—Estradiol—osteoporosis	0.000403	0.00092	CcSEcCtD
Dantrolene—Rash—Zoledronate—osteoporosis	0.0004	0.000913	CcSEcCtD
Dantrolene—Gastrointestinal pain—Estradiol—osteoporosis	0.0004	0.000913	CcSEcCtD
Dantrolene—Dermatitis—Zoledronate—osteoporosis	0.0004	0.000913	CcSEcCtD
Dantrolene—Headache—Zoledronate—osteoporosis	0.000398	0.000908	CcSEcCtD
Dantrolene—Vomiting—Conjugated Estrogens—osteoporosis	0.000388	0.000887	CcSEcCtD
Dantrolene—Urticaria—Estradiol—osteoporosis	0.000388	0.000887	CcSEcCtD
Dantrolene—Abdominal pain—Estradiol—osteoporosis	0.000387	0.000883	CcSEcCtD
Dantrolene—Body temperature increased—Estradiol—osteoporosis	0.000387	0.000883	CcSEcCtD
Dantrolene—Rash—Conjugated Estrogens—osteoporosis	0.000385	0.00088	CcSEcCtD
Dantrolene—Dermatitis—Conjugated Estrogens—osteoporosis	0.000385	0.000879	CcSEcCtD
Dantrolene—Headache—Conjugated Estrogens—osteoporosis	0.000383	0.000874	CcSEcCtD
Dantrolene—Nausea—Zoledronate—osteoporosis	0.000377	0.000861	CcSEcCtD
Dantrolene—Nausea—Conjugated Estrogens—osteoporosis	0.000363	0.000829	CcSEcCtD
Dantrolene—Hypersensitivity—Estradiol—osteoporosis	0.00036	0.000823	CcSEcCtD
Dantrolene—Asthenia—Estradiol—osteoporosis	0.000351	0.000801	CcSEcCtD
Dantrolene—Pruritus—Estradiol—osteoporosis	0.000346	0.00079	CcSEcCtD
Dantrolene—Diarrhoea—Estradiol—osteoporosis	0.000335	0.000764	CcSEcCtD
Dantrolene—Dizziness—Estradiol—osteoporosis	0.000323	0.000738	CcSEcCtD
Dantrolene—Vomiting—Estradiol—osteoporosis	0.000311	0.00071	CcSEcCtD
Dantrolene—Rash—Estradiol—osteoporosis	0.000308	0.000704	CcSEcCtD
Dantrolene—Dermatitis—Estradiol—osteoporosis	0.000308	0.000703	CcSEcCtD
Dantrolene—Headache—Estradiol—osteoporosis	0.000306	0.000699	CcSEcCtD
Dantrolene—Nausea—Estradiol—osteoporosis	0.00029	0.000663	CcSEcCtD
